Constantine Chinoporos
Chief Operating Officer bij APPLIED THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Constantine Chinoporos is currently the Chief Operating & Business Officer at Applied Therapeutics, Inc. Prior to this, he was the Chief Business Officer at Boston Pharmaceuticals, Inc. from 2015 to 2021 and then at Albireo Pharma, Inc. from 2021 to 2023.
He received his undergraduate degree and MBA from Cornell University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-12-2023 | 300 000 ( 0.28% ) | 2 M $ | 31-03-2024 |
Actieve functies van Constantine Chinoporos
| Bedrijven | Functie | Begin |
|---|---|---|
| APPLIED THERAPEUTICS, INC. | Chief Operating Officer | 28-12-2023 |
Eerdere bekende functies van Constantine Chinoporos
| Bedrijven | Functie | Einde |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 01-03-2023 |
Boston Pharmaceuticals, Inc.
 Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-10-2021 |
Opleiding van Constantine Chinoporos
| Cornell University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| APPLIED THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Boston Pharmaceuticals, Inc.
Boston Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Boston Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that leverages a drug development team to advance a portfolio of high value candidates that address important unmet medical needs. The company was founded by Robert Armstrong and Chris Viehbacher and is headquartered in Cambridge, MA. | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
